Search

Your search keyword '"Bouvier, C."' showing total 10 results
Start Over Author "Bouvier, C." Journal annals of oncology
10 results on '"Bouvier, C."'

1. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Author

Salas, S., Resseguier, N., Blay, J.Y., Le Cesne, A., Italiano, A., Chevreau, C., Rosset, P., Isambert, N., Soulie, P., Cupissol, D., Delcambre, C., Bay, J.O., Dubray-Longeras, P., Krengli, M., De Bari, B., Villa, S., Kaanders, J.H.A.M., Torrente, S., Pasquier, D., Thariat, J.O., Myroslav, L., Sole, C.V., Dincbas, H.F., Habboush, J.Y., Zilli, T., Dragan, T., Khanfir, K., Ugurluer, G., Cena, T., Duffaud, F., Penel, N., Bertucci, F., Ranchere-Vince, D., Terrier, P., Bonvalot, S., Macagno, N., Lemoine, C., Lae, M., Coindre, J.M., and Bouvier, C.

Published
2017
Full Text
View/download PDF

2. LBA58 Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REGO) in patients (pts) with relapsed advanced or metastatic chordoma, on behalf of the French Sarcoma Group (FSG) and Unicancer

Author

Duffaud, F., primary, Chabaud, S., additional, Chevreau, C.M., additional, Italiano, A., additional, Perrin, C., additional, Isambert, N., additional, Piperno-Neumann, S., additional, Saada-Bouzid, E., additional, Bertucci, F., additional, Cupissol, D., additional, Kalbacher, E., additional, Narciso, B., additional, Schiffler, C., additional, de Sousa Carvalho, N., additional, Monard, L., additional, Bouvier, C., additional, Vidal, V., additional, Blay, J-Y., additional, and Mir, O., additional

Published
2021
Full Text
View/download PDF

4. LBA68 Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with metastatic relapsed Ewing sarcoma (ES), on behalf of the French Sarcoma Group (FSG) and UNICANCER

Author

Duffaud, F., primary, Blay, J-Y., additional, Mir, O., additional, Chevreau, C.M., additional, Rouquette, P. Boudou, additional, Kalbacher, E., additional, Penel, N., additional, Perrin, C., additional, Laurence, V., additional, Bompas, E., additional, Saada-Bouzid, E., additional, Delcambre, C., additional, Bertucci, F., additional, Cancel, M., additional, Schiffler, C., additional, Monard, L., additional, Bouvier, C., additional, Vidal, V., additional, Gaspar, N., additional, and Chabaud, S., additional

Published
2020
Full Text
View/download PDF

7. Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with locally advanced (LA) or metastatic relapsed chondrosarcoma (CS), on behalf of the French Sarcoma Group (FSG) and UNICANCER

Author

Duffaud, F., primary, Blay, J.-Y., additional, Italiano, A., additional, Bompas, E., additional, Rios, M., additional, Penel, N., additional, Mir, O., additional, Piperno-Neumann, S., additional, Chevreau, C.M., additional, Delcambre, C., additional, Bertucci, F., additional, Boudou Rouquette, P., additional, Vegas, H., additional, Perrin, C., additional, Thyss, A., additional, Schiffler, C., additional, Monard, L., additional, Bouvier, C., additional, Vidal, V., additional, and Chabaud, S., additional

Published
2019
Full Text
View/download PDF

8. LBA88 - Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with locally advanced (LA) or metastatic relapsed chondrosarcoma (CS), on behalf of the French Sarcoma Group (FSG) and UNICANCER

Author

Duffaud, F., Blay, J.-Y., Italiano, A., Bompas, E., Rios, M., Penel, N., Mir, O., Piperno-Neumann, S., Chevreau, C.M., Delcambre, C., Bertucci, F., Boudou Rouquette, P., Vegas, H., Perrin, C., Thyss, A., Schiffler, C., Monard, L., Bouvier, C., Vidal, V., and Chabaud, S.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results